Gsk (GSK) Intangibles (2009 - 2026)
Gsk's Intangibles was $22.54 billion in the quarter ended Jun 30, 2026, up 9.9% from $20.51 billion a year earlier but down 7.8% from the prior quarter.
Powered by 
Analysis
Gsk (GSK) Intangibles (2009 - 2026) Analysis & Trends
As of Dec 31, 2025, Intangibles at Gsk came in at $22.08 billion, up 11.3% from the prior year.
- Intangibles has now increased for three consecutive years, though with a five-year compound annual growth rate of -10.4% (years ended Dec 2020 to Dec 2025).
- In earlier years, Intangibles was $19.83 billion in the year ended Dec 31, 2024 (+8.0%), $18.37 billion in the year ended Dec 31, 2023 (+3.7%), $17.72 billion in the year ended Dec 31, 2022 (-57.2%) and $41.39 billion in the year ended Dec 31, 2021 (+8.1%).
- Quarterly Intangibles has moved between $14.32 billion (the quarter ended Jun 30, 2022) and $41.69 billion (the quarter ended Sep 30, 2021) over five years.
- Compared with a year earlier, Intangibles has increased for 13 straight quarters, with growth averaging 9.4% over the last eight quarters.
- The best year-over-year quarter for Intangibles over five years was the quarter ended Jun 30, 2023 (growth of 35.7%); the worst was the quarter ended Jun 30, 2022 (a decline of 65.1%).
- Per Business Quant data, GSK's Intangibles in the three quarters before the quarter ended Jun 30, 2026 was $24.45 billion (quarter ended Mar 31, 2026), $22.28 billion (quarter ended Dec 31, 2025) and $22.76 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 18.11 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 48.23 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | 24.98 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | 14.03 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 47.05 Bn |
| 10 | Gsk | 100.33 Bn | 81.91 Bn | 8.24 Bn | 22.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.54 Bn |
| Mar 31, 2026 | 24.45 Bn |
| Dec 31, 2025 | 22.28 Bn |
| Sep 30, 2025 | 22.76 Bn |
| Jun 30, 2025 | 20.51 Bn |
| Mar 31, 2025 | 20.48 Bn |
| Dec 31, 2024 | 19.91 Bn |
| Sep 30, 2024 | 19.50 Bn |
| Jun 30, 2024 | 19.53 Bn |
| Mar 31, 2024 | 19.87 Bn |
| Dec 31, 2023 | 18.33 Bn |
| Sep 30, 2023 | 19.37 Bn |
| Jun 30, 2023 | 19.43 Bn |
| Mar 31, 2023 | 17.21 Bn |
| Dec 31, 2022 | 16.79 Bn |
| Sep 30, 2022 | 18.37 Bn |
| Jun 30, 2022 | 14.32 Bn |
| Mar 31, 2022 | 26.04 Bn |
| Dec 31, 2021 | 40.55 Bn |
| Sep 30, 2021 | 41.69 Bn |
API Access
Gsk Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();